Skip to content

Ovation iX Iliac Stent Graft TV-IL1418160-JRecalls & reported problems

Endologix LLC · The Ovation iX™ Iliac Limbs are components of the Ovation Prime, Ovation iX, and Alto™ Abdominal Stent Graft Systems. The Ovation iX™ Iliac Limbs are comprised of a nitinol stent encapsulated in low-permeability PTFE. The iliac limbs are deployed into the leg sections of the aortic body. Additional iliac limbs may be used to extend the length of the device, where indicated. · Class 3 · Implant

All models of Ovation iX Iliac Stent Graft (66)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00850007370374), received between Jul 12, 2023 and Mar 30, 2026 — classified as 5 injuries.

The most frequently reported specific device problem is “Deformation Due to Compressive Stress” (2 reports).

3 other recalls cover devices cleared under the same FDA submission (P120006); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 2 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Deformation Due to Compressive Stress2
  • Obstruction of Flow2
  • Adverse Event Without Identified Device or Use Problem1
  • Device Stenosis1
  • Material Invagination1
  • Migration1
  • Unintended Movement1

Patient problems

  • Clinical Endoleak4
  • Aneurysm3
  • Obstruction/Occlusion2
  • Stenosis2
  • Pain1
  • Pseudoaneurysm1
  • Ruptured Aneurysm1
  • Thrombosis/Thrombus1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 30, 2026Unintended Movement

    THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH AN ALTO MAIN BODY AND TWO (2) OVATION IX ILIAC LIMBS. APPROXIMATELY FOUR (4) MONTHS AFTER POST INITIAL PROCEDURE, THE PATIENT PRESENTED EMERGENTLY TO THE HOSPITAL WITH ABDOMINAL PAIN. AFTER AN ANGIOGRAM, A TYPE 1B ENDOLEAK WAS IDENTIFIED AS WELL AS BOTH ILIAC LIMBS HAD MIGRATED BACK INTO THE ABDOMINAL ANEURYSM. A RE-INTERVENTION WAS DONE AND THE PHYSICIAN ELECTED TO IMPLANT ONE (1) ADDITIONAL OVATION IX LIMB IN EACH ILIAC. THE FINAL PATIENT STATUS WAS REPORTED AS DOING FINE. THIS EVENT WAS PREVIOUSLY REPORTED UNDER 3008011247-2021-00126.NOW, APPROXIMATELY FOUR AND HALF (4.5) YEARS POST THE SECONDARY REINTERVENTION PROCEDURE, A TYPE 1B ENDOLEAK WAS IDENTIFIED. THE RIGHT ILIAC LIMB APPEARS TO HAVE SLIPPED INTO THE ANEURYSM SAC. THE PHYSICIAN ELECTED TO IMPLANT TWO OVATION IX ILIAC LIMBS BY EXTENDING INTO THE EXTERNAL ILIAC ARTERY. THE ENDOLEAK WAS SUCCESSFULLY RESOLVED AND THE PATIENT DID WELL.

    Patient problems: Aneurysm; Clinical Endoleak

    MAUDE report 24712324 ↗
  • InjuryNov 14, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2025 WITH THE IMPLANT OF AN ALTO ABDOMINAL STENT GRAFT SYSTEM. THE PATIENT PRESENTED TO THE HOSPITAL ON (B)(6) 2025 WITH A POSSIBLE KIDNEY INFECTION, AND IT WAS THEN REALIZED THAT THE RIGHT COMMON ILIAC LIMB EXTENSION HAD A DISEASED ANEURYSM SEGMENT WHICH CONTINUED AND DISEASE PROGRESSION. REINTERVENTION TOOK PLACE ON (B)(6) 2025 IN WHICH THE PHYSICIAN DECIDED TO COIL EMBOLIZE THE RIGHT INTERNAL ILIAC ARTERY (RIIA) AND EXTEND THE LIMB FURTHER INTO THE EXTERNAL ILIAC ARTERY BY IMPLANTING AN OVATION IX ILIAC LIMB. THE PATIENT ALSO HAD AN EXTREMELY PATENT INFERIOR MESENTERIC ARTERY (IMA) SO THE PHYSICIAN ALSO COIL EMBOLIZED THE IMA VIA SUPERIOR MESENTERIC ARTERY. IT IS BELIEVED THAT THE PATIENT HAD A PATENT TYPE II ENDOLEAK (NON-DEVICE RELATED) WHICH WAS CAUSING THE SAC EXPANSION FROM THE IMA. THE PATIENT STATUS WAS REPORTED TO BE DOING WELL AND RECOVERING FROM THE PROCEDURE. THE FINAL PATIENT STATUS WAS REPORTED AS DISCHARGED HOME FROM SUBACUTE REHAB ON POSTOPERATIVE DAY TWENTY IN FAIR CONDITION.

    Patient problems: Aneurysm; Clinical Endoleak; Unspecified Infection

    MAUDE report 23556185 ↗
  • InjuryMar 27, 2024Obstruction of Flow; Deformation Due to Compressive Stress; Device Stenosis; Obstruction of Flow; Deformation Due to Compressive Stress; Device Stenosis

    THE PATIENT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2024, WITH THE IMPLANTATION OF THE ALTO STENT GRAFT SYSTEM. DURING THE PROCEDURE, IT WAS REPORTED THAT THE AORTIC ANATOMY SHOWED TWO 90-DEGREE INFRARENAL ANGLES. THE POLYMER WAS MIXED PER THE INSTRUCTIONS FOR USE (IFU), ATTACHED TO THE POLYMER PORT, AND ADVANCED WITH AN AUTOINJECTOR. INITIALLY, THE IPSILATERAL LIMB FILLED, BUT NOT THE RINGS OR CONTRALATERAL LIMB. THE PHYSICIAN THEN MOVED THE HANDLE OF THE ALTO DELIVERY SYSTEM AND PROCEEDED TO PUT A LITTLE BACK TENSION ON THE DELIVERY SYSTEM AND INFLATE THE INTEGRATED BALLOON. THE SEALING AND SUPPORT RING WERE PARTIALLY FILLED AFTER TROUBLESHOOTING. THE CONTRALATERAL LIMB NEVER FILLED. THE PHYSICIAN THEN CANNULATED THE CONTRALATERAL GATE USING THE CROSSOVER LUMEN, AND THE CONTRALATERAL LIMB DEPLOYED WITHOUT DIFFICULTY. THE ALTO DELIVERY SYSTEM WAS SUCCESSFULLY REMOVED WITHOUT ANY COMPLICATIONS. THE IPSILATERAL LIMB ALSO DEPLOYED WITHOUT ANY DIFFICULTY. AN ANGIOGRAM SHOWED A TYPE IA ENDOLEAK, SO THE PHYSICIAN THEN DEPLOYED A (NON-ENDOLOGIX DEVICE) 40/10 PALMAZ AT THE RINGS. THIS SUCCESSFULLY RESOLVED THE TYPE IA ENDOLEAK. THE PATIENT'S STATUS WAS REPORTED AS HAV

    Patient problems: Obstruction/Occlusion; Stenosis

    MAUDE report 18986377 ↗
  • InjuryMar 21, 2024Material Invagination; Obstruction of Flow; Deformation Due to Compressive Stress; Material Invagination; Obstruction of Flow; Deformation Due to Compressive Stress

    THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH IMPLANT OF THE ALTO ABDOMINAL AORTIC ANEURYSM STENT SYSTEM. APPROXIMATELY TWO (2) DAYS POST INITIAL PROCEDURE, THE PATIENT RETURNED WITH RIGHT LEG PAIN. THE CT (COMPUTED TOMOGRAPHY) SCAN NOTED THAT THE RIGHT ILIAC LIMB WAS KINKED AND HAD THROMBUS WITHIN GRAFT. THE PHYSICIAN ELECTED TO TREAT THE PATIENT WITH THROMBECTOMY AND IMPLANTED AN OVATION IX ILIAC LIMB. PATIENT IS REPORTEDLY STABLE, AND THROMBUS WAS SUCCESSFULLY RESOLVED.

    Patient problems: Clinical Endoleak; Obstruction/Occlusion; Pain; Thrombosis/Thrombus

    MAUDE report 18952431 ↗
  • InjuryJul 12, 2023Migration; Migration

    THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH IMPLANT OF THE ALTO ABDOMINAL AORTIC ANEURYSM STENT SYSTEM. APPROXIMATELY THREE (3) MONTHS POST INITIAL PROCEDURE, THE PATIENT WAS READMITTED ON 17 FEBRUARY 2023 FOR COILING OF THE LEFT INTERNAL ILIAC ARTERY WITH LEFT ILIAC STENT PLACEMENT DUE TO A TYPE IB ENDOLEAK, LEFT ILIAC PSEUDOANEURYSM, CRANIAL MIGRATION AND ANEURYSM ENLARGEMENT. THE PATIENT WAS DISCHARGED FOR A BRIEF PERIOD. NO ADDITIONAL INFORMATION IS CURRENTLY AVAILABLE REGARDING THIS INITIAL REPORT. ADDITIONAL INFORMATION: CLINICAL ASSESSMENT IDENTIFIED THAT A SUSPECT, CONTAINED RUPTURE IN THE PATIENT'S AORTA WAS INDICATED PER INTERNAL CLINICAL DOCUMENTATION DATED 16 FEBRUARY 2023. IN ADDITION, AORTIC STENOSIS WAS INDICATED PER INTERNAL CLINICAL DOCUMENTATION AND CT (COMPUTED TOMOGRAPHY) SCANS DATED 19 DECEMBER 2022 AND 16 FEBRUARY 2023.

    Patient problems: Aneurysm; Clinical Endoleak; Pseudoaneurysm; Ruptured Aneurysm; Stenosis

    MAUDE report 17311557 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P120006. One submission often covers many models, so check the product and lot details in each record.

  • Z-2263-2020 · May 6, 2020 · Terminated
    Ovation iX Abdominal Stent Graft Systems, REF: TV-AB2080-I, TV-AB2080-J, TV-AB2380-I, TV-AB2380-J, TV-AB2680-I, TV-AB2680-J, TV-AB2980-I, TV-AB2980-J, TV-AB3480-I, TV-AB3480-J
  • Z-0125-2015 · Sep 20, 2014 · Terminated
    Ovation Prime Abdominal Stent Graft System - 29mm Aortic Body stent grafts. The TriVascular Ovation Prime Abdominal Stent Graft System is a low-profile endovascular device deliver
  • Z-0288-2013 · Oct 19, 2012 · Terminated
    TriVascular brand Fill Polymer Kit, Endovascular Graft, Aneurysm Treatment System, European Model Number: TVFP14-B, (in European distributor inventory only); PRODUCT Usage: The

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page